Chartwell Investment Partners, LLC Ptc Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$33.33 - $44.6 $177,548 - $237,584	-5,327 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$35.36 - $41.86 $6,117 - $7,241	-173 Reduced 3.15%	5,327 $212,000
Q2 2021 Jul 19, 2021	BUY	$37.95 - $49.37 $1,973 - $2,567	52 Added 0.95%	5,500 $232,000
Q1 2021 May 03, 2021	SELL	$46.8 - $68.92 $13,665 - $20,124	-292 Reduced 5.09%	5,448 $258,000
Q4 2020 Feb 09, 2021	SELL	$47.96 - $67.64 $62,300 - $87,864	-1,299 Reduced 18.45%	5,740 $350,000
Q2 2020 Jul 29, 2020	SELL	$42.56 - $54.98 $109,251 - $141,133	-2,567 Reduced 26.72%	7,039 $357,000
Q1 2020 Apr 30, 2020	BUY	$32.37 - $59.36 $25,766 - $47,250	796 Added 9.04%	9,606 $429,000
Q4 2019 Jan 29, 2020	BUY	$32.22 - $50.07 $283,858 - $441,116	8,810 New	8,810 $423,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.